Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China
about
Clinical utility of entecavir for chronic hepatitis B in Chinese patientsThe Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis BEnhancing adverse drug event detection in electronic health records using molecular structure similarity: application to pancreatitisEarly hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis.Safety and efficacy of entecavir for the treatment of chronic hepatitis B.Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B.A review of oral antiretroviral therapy for the treatment of chronic hepatitis B.Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients.Detectability and clinical significance of serum hepatitis B virus ribonucleic acidCost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China.Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.Similar response to entecavir 0.5 and 1.0 mg in treatment-naïve chronic hepatitis B patients: a case-control study.Antiviral efficacy of entecavir in nucleos(t)ide-naïve patients of Black/African descent with chronic hepatitis B.Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a ‘real-world’ clinical practice setting in China.Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.
P2860
Q26830371-E71B44DC-1C72-450B-A422-7D9262A6FA70Q27007019-E0A26BBF-A128-4D8C-AE2E-5892CF801446Q28481490-DEF5C2D6-5337-4A91-BD67-50ABAB006064Q34601513-9B15F9BF-E949-435A-8FF6-EC49319EE46FQ34623662-05728EAB-721B-42AF-845B-12493379B3E6Q35026611-7303EA57-F592-42A9-94DB-9F7C018D8EDAQ35819595-05C8DE14-159E-488E-9657-C9282B5C83F0Q37488838-C1DBFD44-BB93-426D-8D1A-B722958260D8Q37768591-40BD4E35-D6B8-41E2-9C42-277E16DA80A9Q37964712-4036B3B6-ADC4-4975-BCD1-74868C45BB54Q38074916-28129449-79C2-4B54-B57B-04187DF308C6Q38086312-381039AC-3FE0-4D5E-8895-1F1ADEE7C801Q38543533-C736074F-478B-4273-A526-97359B15E347Q39121074-128B3BCA-2E48-49BD-A063-46B77AC5D3B8Q41869433-B1C7006A-4D0E-4078-9E27-0930191F71D7Q42254708-7EA22979-66A6-48A2-8C27-85FE0CC13605Q42263564-7360FE23-D7F2-4F79-8100-8DAE733AF1E8Q42282218-FBAC7A37-2931-4F21-922C-7A52CDD40BAAQ45002798-69B27DF4-8CD4-45A6-9771-471C51BB5C5B
P2860
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of entecav ...... ed double-blind trial in China
@en
Efficacy and safety of entecav ...... d double-blind trial in China.
@nl
type
label
Efficacy and safety of entecav ...... ed double-blind trial in China
@en
Efficacy and safety of entecav ...... d double-blind trial in China.
@nl
prefLabel
Efficacy and safety of entecav ...... ed double-blind trial in China
@en
Efficacy and safety of entecav ...... d double-blind trial in China.
@nl
P2093
P2860
P1476
Efficacy and safety of entecav ...... ed double-blind trial in China
@en
P2093
AI463023 Study Group
Chengwei Chen
Daozheng Xu
Deming Tan
Guangbi Yao
Jessica Liu
Laurie Macdonald
P2860
P2888
P304
P356
10.1007/S12072-007-9009-2
P577
2007-07-31T00:00:00Z